A nurse is reviewing the laboratory values of a client who is taking atorvastatin. Which of the following laboratory values indicates the treatment has been effective?
BUN 15 mg/dl.
LDL 120 mg/dL
Urine specific gravity 1.020
Blood glucose 90 mg/dl
The Correct Answer is B
A. BUN 15 mg/dL:
Incorrect Explanation: Blood urea nitrogen (BUN) is not a specific marker for assessing the effectiveness of atorvastatin treatment.
Explanation: BUN is a measure of kidney function and the breakdown of protein in the body. It is not directly related to the cholesterol-lowering effects of atorvastatin.
B. LDL 120 mg/dL.
Explanation:
Atorvastatin is a medication used to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, which is often referred to as "bad" cholesterol. Elevated LDL cholesterol levels are a risk factor for cardiovascular disease. The goal of using medications like atorvastatin is to reduce LDL cholesterol levels to a target range, as recommended by healthcare guidelines.
A lower LDL cholesterol level indicates that the treatment with atorvastatin has been effective in achieving the desired therapeutic goal of lowering cholesterol levels and reducing the risk of cardiovascular events. Therefore, a decrease in LDL cholesterol is a positive outcome of atorvastatin therapy.
C. Urine specific gravity 1.020:
Incorrect Explanation: Urine-specific gravity is not a marker for assessing the effectiveness of atorvastatin.
Explanation: Urine-specific gravity measures the concentration of urine and is related to hydration status and kidney function. It is not used to evaluate the effectiveness of cholesterol-lowering medications like atorvastatin.
D. Blood glucose 90 mg/dL:
Incorrect Explanation: A blood glucose level of 90 mg/dL is not indicative of the effectiveness of atorvastatin treatment.
Explanation: Blood glucose level measures the amount of sugar in the bloodstream and is unrelated to the cholesterol-lowering effects of atorvastatin.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Insert the needle at least 5 cm (2 in) from the umbilicus: Correct. Subcutaneous injections, including heparin, should be given in fatty tissue away from major blood vessels and bony prominences. The recommended sites are usually the abdomen, thighs, or upper arms.
B. Aspirate before injecting the medication: Incorrect. Aspiration is not required for subcutaneous injections because they are administered into the subcutaneous fat layer, not a blood vessel. Aspiration could cause trauma and discomfort to the client.
C. Massage the site after administering the medication: Incorrect. Massaging the site after administering heparin can cause bruising or discomfort. Instead, it's recommended to apply gentle pressure with a sterile gauze pad for a few seconds.
D. Use a 21-gauge needle for the injection: Incorrect. Subcutaneous injections are typically administered with smaller gauge needles, such as 25-30 gauge, to minimize pain and tissue damage.
Correct Answer is D
Explanation
A. The client's absolute neutrophil count was 2.500/mm³ before the medication was administered:
Incorrect Explanation: This is a normal data point that does not suggest an adverse event or error.
Explanation: An absolute neutrophil count of 2.500/mm³ is within the normal range, and there is no indication of a problem related to the administration of filgrastim based on this information.
B. The nurse flushed the client's IV line with dextrose 5% in water before and after the medication was administered:
Incorrect Explanation: Routine flushing of the IV line with appropriate solutions is a standard practice and not indicative of an incident.
Explanation: Flushing the IV line with dextrose 5% in water before and after medication administration is a routine procedure to maintain line patency and prevent interactions between medications.
C. The client had chemotherapy 12 hours before the medication was administered:
Incorrect Explanation: The timing of chemotherapy does not necessarily indicate an incident.
Explanation: Knowing the timing of chemotherapy is important for overall patient care, but it doesn't necessarily indicate an incident or error related to the administration of filgrastim.
D. The medication vial sat at room temperature for 2 hours before it was administered:
Correct Answer: This is the data point that should lead to filing an incident report.
Explanation: Many medications, including filgrastim, have specific storage requirements to ensure their effectiveness and safety. Allowing a medication vial to sit at room temperature for an extended period can compromise its stability and effectiveness. This situation should be reported as it involves a potential deviation from proper medication storage and handling procedures.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.